TY  - JOUR
AU  - Marques, Vanda
AU  - Afonso, Marta B
AU  - Bierig, Nina
AU  - Duarte-Ramos, Filipa
AU  - Santos-Laso, Álvaro
AU  - Jimenez-Agüero, Raul
AU  - Eizaguirre, Emma
AU  - Bujanda, Luis
AU  - Pareja, Maria J
AU  - Luís, Rita
AU  - Costa, Adília
AU  - Machado, Mariana V
AU  - Alonso, Cristina
AU  - Arretxe, Enara
AU  - Alustiza, José M
AU  - Krawczyk, Marcin
AU  - Lammert, Frank
AU  - Tiniakos, Dina G
AU  - Flehmig, Bertram
AU  - Cortez-Pinto, Helena
AU  - Banales, Jesus M
AU  - Castro, Rui E
AU  - Normann, Andrea
AU  - Rodrigues, Cecília M P
PY  - 2021
DO  - 10.3389/fmed.2021.683250
SN  - 2296-858X
UR  - http://hdl.handle.net/10668/18189
T2  - Frontiers in medicine
AB  - Background: Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease where liver biopsy remains the gold standard for diagnosis. Here we aimed to evaluate the role of circulating adiponectin, leptin, and insulin-like growth...
LA  - en
KW  - IGF-1
KW  - NAFLD
KW  - adiponectin
KW  - circulating biomarkers
KW  - fibrosis
KW  - leptin
KW  - lipid metabolism
TI  - Adiponectin, Leptin, and IGF-1 Are Useful Diagnostic and Stratification Biomarkers of NAFLD.
TY  - research article
VL  - 8
ER  -